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CHAPTER 1
Introduction
The neural basis of decision making has long been elusive and often considered to be
too broad of a problem to be tractable. Several authors (Fuster, 2001;Goldman-Rakic,
1996;Krawczyk, 2002;Miller, 1999) have presented the prefrontal cortex (PFC) as the
key brain region associated with high-level, “executive” processes needed for voluntary
goal-directed behavior. Evidence for this includes an extensive neurological history of
aberrations in the decision making process of patients with sustained lesions in the
frontal regions of the brain. Ever since Harlow (Harlow, 1999) described the famous
case of Phineas Gage, it has been known that lesions in orbital PFC often produce
dramatic changes in personality (Damasio et al., 1994). Despite the extensive literature
describing this type of abnormality, little is known about the molecular and cellular
mechanisms within the PFC that regulate neuronal excitability and could eventually
underlie the process of decision making and other brain functions driven by the
prefrontal cortex.
Multiple studies have correlated changes of activity in the PFC with diverse behavioral
manifestations, in example, in vivo studies have found multiplicative effects on firing rate
during changes in attention or behavioral state (McAdams and Reid, 2005). Several
mechanisms have been proposed, including variations in background noise, inhibitory
synchrony and neuronal inhibition in order to explain how alterations in neuronal firing
rates can lead to changes in behavior. Higgs (Higgs et al., 2006) described a
mechanism of modulation of input gain, capable of modifying input signals of pyramidal
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neurons. In these cells, large afterhyperpolarizations promote suprathreshold
coincidence detection and gain increase, thus allowing them to discriminate between
input stimuli into pyramidal neurons. This study highlights the relevance of these
afterpotentials in the regulation of neuronal excitability of pyramidal neurons in the
prefrontal cortex which ultimately might contribute to the understanding of higher brain
process such as human decision making.
Afterhyperpolarizations in cortical pyramidal cells
The afterhyperpolarizations seen in pyramidal cells have been dissected into three
components based on their pharmacological and kinetic features and named the fast
afterhyperpolarization (fAHP), the medium AHP (mAHP), and the slow AHP (sAHP). The
fAHP is activated during a single action potential and lasts tens of milliseconds. Single
channel recordings identified a large conductance Ca 2+-activated K+ channel sensitive to
tetraethylammonium (TEA), termed BK or maxi-K channel, to be the channel underlying
the fAHP (Adams et al., 1982;Marty, 1981;Pallotta et al., 1981). The mAHP, and its
underlying current (ImAHP), is also rapidly activated following the action potential (<5 ms)
but decays with a time course of several hundred milliseconds. This afterpotential is
inhibited by the bee-venom toxin apamin, and thus is referred to as the apaminsensitive component of the AHP (Schwindt et al., 1988a;Storm, 1989). There is
accepted consensus that small-conductance Ca 2+-dependent K+ (KCa2.X; SK1-3)
channels are responsible for the appearance of this current (Bond et al., 2004;Schwindt
et al., 1988b;Stocker et al., 1999;Villalobos et al., 2004). Finally, the third component of
the AHP, the sAHP, is generally seen after a train (4-10) of spikes (Faber et al.,
2001;Lancaster and Nicoll, 1987;Schwindt et al., 1988b), rises to a peak over several
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hundred milliseconds and can last up to 5 seconds following a train of action potentials.
The identity of the channel(s) underlying the sAHP has proven elusive. Initial studies
suggested that a member of the SK Ca channels family (KCa2.1, SK1) could be a potential
molecular candidate for sAHP (Bond et al., 1999;Kohler et al., 1996;Vergara et al.,
1998). However, more recent studies have shown that SK Ca channels are solely
responsible for the ImAHP and do not contribute to the IsAHP (Bond et al., 2004;Villalobos et
al., 2004). Thus the identity of the Ca 2+-activated K+ channel(s) underlying the sAHP
remains an unsolved mystery.
The sAHP
In the early 1980s, a series of studies described and characterized the properties of the
long lasting sAHP that followed firing of neurons in the central nervous system. This
series of studies showed that this hyperpolarizing potential was mediated by calciumdependent potassium currents activated following action potentials or epileptiform burst
in hippocampal CA1-CA3 pyramidal neurons and other cell types (Alger and Nicoll,
1980;Hotson and Prince, 1980;Schwartzkroin and Stafstrom, 1980). This long lasting
sAHP controls spike frequency accommodation in these cells (Faber and Sah,
2003;Vogalis et al., 2003) and regulates neuronal gain (Higgs et al., 2006). Similar
sAHPs have also been reported in many other cell types, suggesting that the sAHP
functions as a ubiquitous regulator of neuronal excitability. A general property of this
sAHP is that it is inhibited by neuromodulators acting through the Gαq-11/Phospholipase
Cβ or through the Gαs/adenylate cyclase/cAMP/Protein kinase A signaling cascades
(Krause et al., 2002;Nicoll, 1988;Pedarzani and Storm, 1993). Thus the sAHP is an
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important determinant of cellular excitability in a variety of cell types in the CNS and an
important target for a variety of neuromodulators.
Calcium activation of IsAHP
Although IsAHP is understood as a potassium current activated by calcium influx through
voltage activated calcium channels, exactly how these potassium channels are gated by
calcium remains unclear. One clue in this regard is that the slow rise and decay of this
current has been reported to track intracellular bulk calcium rather than the calcium
concentration immediately below the plasma membrane (Abel et al., 2004;Jahromi et
al., 1999;Sah and Clements, 1999). Several hypotheses have been proposed to explain
this observation, among them, that the channels involved in I sAHP activation would be
located far from the point of calcium influx, therefore the time course of the macroscopic
currents will simply reflects the diffusion of free calcium to the K + channels. Another
theory suggests that the kinetic of the macroscopic currents is due to the slow kinetic of
the underlying channels. Even though these hypotheses could explain the kinetics
differences between calcium influx and I sAHP, evidence discarding them was soon
obtained (Lancaster and Adams, 1986;Lancaster and Nicoll, 1987;Sah, 1995;Sah and
Isaacson, 1995;Sah and McLachlan, 1991;Schwindt et al., 1992). A third theory has
proposed that calcium influx might activate a second messenger system, which
ultimately opens the channels that underlie the I sAHP thus explaining the discrepancy
between calcium influx and I sAHP kinetics (Abel et al., 2004;Gerlach et al., 2004;Sah,
1996a;Schwindt et al., 1988a).
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A recent breakthrough into elucidating the mechanism of I sAHP was the observation that
genetic deletion of hippocalcin, a member of the neuronal calcium sensor (NCS) protein
family, resulted in an inhibition of this current in hippocampal pyramidal cells. In
addition, expression of hippocalcin in primary culture of hippocampal neurons induced
the appearance of a robust IsAHP (Tzingounis et al., 2007). These results have led to the
idea that hippocalcin is the calcium sensor for the I sAHP (Tzingounis et al., 2007).
However, this idea is not without its limitations. First, while I sAHP is broadly expressed in
many regions of the brain, hippocalcin expression seems to be much more restricted
(Paterlini et al., 2000;Saitoh et al., 1994). Furthermore, hippocalcin deletion inhibits but
does not abolish IsAHP. These considerations suggest that other proteins besides
hippocalcin may be capable of functioning as a calcium sensor for I sAHP.
Ion channels mediating IsAHP
In spite of very extensive efforts by many groups, little is known at the present time
about the identity of the channels carrying I sAHP. For example, single channel analyses
have shown remarkable heterogeneity in the properties of putative I sAHP channels in
different cells (Vogalis et al., 2003). Furthermore, genetic and pharmacological
approaches have shown that while Kv7 (KCNQ) channels contribute in part to I sAHP in
granule cells of the dentate gyrus, they do not contribute to I sAHP in pyramidal cells of the
CA1 region (Tzingounis and Nicoll, 2008). These observations raise the possibility that
IsAHP may not be a unitary current and may be carried by different potassium channels
depending on the cellular background.
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To know how IsAHP is modulated would be an important contribution to our understanding
of how neuronal excitability is regulated in PFC because the sAHP plays an important
role in setting the neuronal gain and is regulated by a variety of neuromodulators. Since
recent evidence tend to suggest that I sAHP may not be product of a single calciumactivated potassium channel, but rather multiple channels, the understanding of how
IsAHP gets modulated becomes of greater importance. A distinctive feature of I sAHP is its
modulation by several neurotransmitters, however, the intracellular pathways and
second messengers involved in this process tend to vary depending on the brain region
and cell type tested [reviewed in (Nicoll, 1988;Sah, 1996b)]. The mechanism of I sAHP
inhibition by monoamines (noradrenaline, dopamine, histamine, and serotonin) involves
cAMP as a second messenger and the activation of protein kinase A (Andrade and
Nicoll, 1987a;Benardo and Prince, 1982;Haas and Konnerth, 1983;Madison and Nicoll,
1986b;Madison and Nicoll, 1982;Madison and Nicoll, 1986a;Pedarzani and Storm,
1993;Torres et al., 1995). Protein kinase A, as well as protein kinase C do not take part
in the modulation of IsAHP by muscarinic and mGluR agonist (Blitzer et al., 1994;Gerber
et al., 1992;Pedarzani and Storm, 1993;Sim et al., 1992). Furthermore, cAMP/PKA
pathway seems not to be involved in I sAHP inhibition by either serotonin or muscarinic
receptor activation in pyramidal neurons of PFC; instead PLC/IP 3-DAG seems to be the
intracellular pathway of choice. These multiple intracellular signaling pathways, together
with the hypothesis of multiple ion channels involved in I sAHP activation, lead to the idea
that IsAHP activation and modulation form part of a ubiquitous mechanism for regulation of
neuronal excitability rather than be a particular feature of a specific neuronal type.
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In the present dissertation I investigate the role of hippocalcin, and other NCS proteins,
in the regulation of IsAHP in pyramidal neurons of the prefrontal cortex. I also show that
PtdIns(4,5)P2 is essential for the functional expression and gating of I sAHP and that this
phosphoinositide acts downstream from calcium in the gating of I sAHP.
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CHAPTER 2
Material & Methods
Brain slices experiments. Whole-cell recordings were obtained from pyramidal cells of
layer V of the anterior cingulate and somatosensory cortex derived from rat and mouse
brain slices. For these experiments we used either acute brain slices prepared from
animals aged postnatal day 15 to 30 (P15-P30) or slices in organotypic culture derived
from animals aged postnatal day 8-12 (P8-P12) maintained in culture from 2-3 days. To
prepare the brain slices, the anterior pole of the brain was removed and cooled in ice
cold cutting Ringer (composition in mM: 119 NaCl, 2.5 KCl, 1.3 MgSO 4, 2.5 CaCl2, 1
NaH2PO4, 26.2 NaHCO3, 10 HEPES and 11 glucose; bubbled to saturation with 95%O 2,
5%CO2). The isolated brain was then affixed to a block with cyanoacrylate glue, and cut
using a vibratome (Lancer series 1000, Ted Pella, Irvine, CA) to produce 300µM thick
coronal brain slices. Acute slices were transferred to a holding chamber where they
were allowed to recover for at least 1 h in same cutting Ringer’s solution.
Electrophysiological recordings. Brain slices were placed one at a time in a recording
chamber (Sakmann and Stuart, 1995) on the stage of a Nikon (Melville, NY) E600FN
microscope. Slices were superfused with standard Ringer’s solution (in mM: 119 NaCl,
2,5 KC, 125 KmeSO4, l, 1.3 MgSO4, 2.5 CaCl2, 1 NaH2PO4, 26.2 NaHCO3, and 22
glucose, bubbled to saturation with 95% O 2-5% CO2) at 30°±1°C. Neurons were
visualized using differential interference contrast (DIC) or fluorescence, and recordings
were obtained using 3-4 MΩ electrodes filled with a potassium-based intracellular
solution (in mM: 125 KMeSO4, 5 KCl, 5 NaCl, 0.02 EGTA, 11 HEPES, 1 MgCl 2, 10 Na2
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phosphocreatine, 4 MgATP, and 0.3 NaGTP; pH 7.3). In some experiments this
intracellular solution was supplemented with 10-30mM of myo-inositol (Fisher et al.,
2002) and the concentration of KMeSO 4 was reduced to maintain osmotic equilibrium.
Signals were amplified using Multiclamp 700B (Molecular Devices, CA), digitized and
stored. In voltage-clamp experiments, cells were held at -60mV and AHP currents were
elicited using 100-msec long steps to +20mV in 1µM TTX to prevent spontaneous
synaptic potentials and allow calcium into the cell to trigger the AHPs (Stocker et al.,
1999). ImAHP was measured 30-50 msec after the end of the depolarizing step, a time
empirically determined to correspond to the peak of the apamin-sensitive I mAHP. IsAHP was
measured ∼300 msec after the end of the depolarizing step, when I sAHP is near its peak
and ImAHP has decayed by ∼90% (Abel et al., 2004). For calcium measurements,
electrodes were filled with an intracellular recording solution containing (in mM): 130.5
KMeSO4, 10 KCl, 7.5 NaCl, 2 MgCl2, 10 HEPES, 2 ATP, 0.2 GTP and 100µM fura-2
pentapotassium salt (Molecular Probes/Invitrogen, Carlsbad, CA).
Plasmid transfection. Pyramidal neurons were transfected using either in utero
electroporation (RNAi experiments) or particle mediated gene transfer (GFP-PH PLCδ1,
InPP5B and NCS expression experiments). In utero electroporation, experiments were
conducted on embryonic mice at embryonic gestation day 13 to 14 (E13-14) essentially
as described by Saito (Saito, 2006). These experiments used a pool of five shRNAs
targeting hippocalcin to maximize the suppression of hippocalcin expression (Parsons
et al., 2009). These shRNAs have been developed by the RNAi consortium and were
expressed from the U6 promoter in the pLKO.1-puro vector (Sigma, Mission RNAi). YFP
in pCAG (Addgene) at 4:1 ration was electroporated with the shRNA as a transfection
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marker. Particle mediated gene transfer in slices maintained in organotypic culture was
conducted as previously described (Villalobos et al., 2004;Yan et al., 2009). Gold
particles were coated with plasmids encoding for the desired protein (GFP-PH PLCδ1: a
kind gift of Dr. Tobias Meyer, Stanford), InPP5B: in pCMV-Sport6, ATCC Cat No.
10324723/Mammalian Gente Collection, Image ID 4457437; hippocalcin: in pCMVSport6, ATTCC Cat. No. 10470251/Mammalian Gene Collection, Image ID 5360894);
neurocalcin-δ: in pCMV-Sport6, ATCC Cat. No. MGC-36496/Mammalian Gene
Collection, Image ID 5365560; VILIP-2: in pcDNA3.1, a kind gift of Dr W.A. Catterall,
Univ. of Washington (Lautermilch et al., 2005)). EGFP (pEGFP-N1, Clontech) or mcherry at a 4:1 ratio was cotransfected as transfection marker. In all these vectors,
expression of the protein mRNA was driven by CMV promoter, which effectively drives
gene expression in this preparation (Beique and Andrade, 2003;Vogalis et al., 2003).
Transgenic animals. The PLCβ1 knockout mouse was a kind gift of Drs. R.K. Wong
(Suny Downstate Medical Center, Brooklyn, Ny) and H.S. Shin (Korea Institute of
Science and Technology, Seoul, Korea) (Kim et al., 1997).
Experimental strategy. Experiments examining the effect of the shRNA targeting
hippocalcin compared pyramidal neurons in the transfected side of the brain, as
identified by expression of YFP, with untransfected pyramidal neurons at the same
cortical depth on the opposite side of the brain. We chose to use cells in the
nontransfected contralateral side because preliminary studies indicated that while YFP
allowed for clear identification of transfected neurons, lack of detectable YFP expression
in vivo could not be used to unambiguously select for untransfected neurons in the
transfected brain hemisphere.
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In gene transfer experiments, overexpression of the desired protein was generally
assessed using paired recordings from neighboring transfected and untransfected
pyramidal neurons located within 150 µm of each other at a comparable cortical depth.
This approach was preferred to using mock transfection in separate slices from controls
as it provided for a more stringent cell match with respect to cell location and slice
history. We have previously shown that transfection with EGFP has no detectable effect
on IsAHP (Yan et al., 2009) and the very low transfection efficiency of the gene gun
technique assured that the overwhelming fraction of non-GFP expressing cells will
correspond to untransfected neurons.
Drugs were prepared as concentrated stock in H 20 and kept frozen. They were thawed
immediately before the experiments and administered to the slice dissolved in the
standard Ringer solution at known concentration. Most drugs were obtained from Sigma
or Fisher. Tetrodotoxin (TTX) was obtained from Calbiochem/EMD Biosciences. Apamin
was obtained from Tocris. Statistical comparisons used t-test.
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CHAPTER 3
Role of Neuronal Calcium Sensor (NCS) Proteins in the Development of Slow
Afterhyperpolarizing Currents
Depolarizing steps are capable of opening voltage-activated calcium channels in cortical
pyramidal cells and the consequent calcium influx activates calcium-activated
potassium channels which in turn elicit a biphasic aftehyperpolarizing current. As
outlined in the introduction, this calcium-activated aftercurrent is known to be composed
of two kinetically and pharmacologically distinctly currents, an early faster apaminsensitive component (ImAHP), mediated by KCa2.X (SK) channels and a late, slow apamininsensitive component (IsAHP). IsAHP can be pharmacological isolated by using low
concentration of the bee venom apamin (300nM, applied to the bath) which specifically
inhibits SK channels, therefore abolishing selectively the I mAHP (Fig1A). Unless otherwise
noted, most of the experiments involving I sAHP measurements were recorded in the
present of apamin to avoid ImAHP contamination.
To detect optimal conditions for eliciting I sAHP, pyramidal cells were held at -60mV in
voltage-clamp configuration and voltage step increments from -60 to +30mV were
applied. This protocol induced increasing calcium influx and elicited I sAHP of escalating
amplitudes (Fig 1B). The amplitude of the resulting I sAHP increased in a sigmoid fashion
and reached a plateau close to +20mV (Fig 1C). Therefore we used 100ms depolarizing
steps to +20mV as the standard way to activate I sAHP unless otherwise mentioned.
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Figure 1. IsAHP in pyramidal cells of the
prefrontal cortex. A. Representative trace of
an afterhyperpolarizing current elicited using a
depolarizing pulse from -60mV to +20mV in
the absence (black trace) and presence of
apamin (300nM, red trace). B. IsAHP elicited
using a 100ms long step from -60mV to -40,
-20 and +20mV recorded in the presence of
apamin. C. Dependence of IsAHP amplitude on
the triggering voltage step amplitude. The
cells were held at -60mV and IsAHP was elicited
using 100ms long depolarizing steps to the
voltage indicated in the X axis. Current
amplitude was normalized with respect to the
maximal current obtained for each cell. n = 15
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Role of hippocalcin on IsAHP development in pyramidal neurons of the prefrontal cortex
As mentioned above, the observation that genetically modified mice lacking the NCS
protein hippocalcin showed reduced I sAHP amplitude lead Tzingounis (Tzingounis et al.,
2007) to hypothesize of a significant role of this protein in the development of I sAHP. To
test this idea we aimed to reduce the levels of hippocalcin in pyramidal neurons of the
prefrontal cortex to assess its role as the putative protein responsible for the I sAHP. In a
first set of experiments, we used in utero electroporation to express a pool of shRNAs to
knockdown hippocalcin in layer II/III pyramidal cells of cingulated cortex. Previous
studies have shown the effectiveness of this approach to knockdown the expression of
specific proteins (Bai et al., 2003;Parsons et al., 2009). However, because the in utero
electroporation approach has not been used before to study electrophysiological effects
in the medial prefrontal/anterior cingulated cortex we first sought to test the
effectiveness of the transfection system in this area. To that effect we transfected YFP
fluorescent protein together with the potassium channel Kir2.1 into mice (E14) in order
to obtain both a fluorescent and a biological marker of positively transfected cells. As
expected, we found sparse labeling of layer II/III pyramidal cells showing green
fluorescence in only one hemisphere in slices obtained from transfected mice (slices
obtained from mice P10-21). At the electrophysiological level, pyramidal cells
expressing YFP/Kir2.1 showed a more hyperpolarized membrane resting potential than
neighboring non-fluorescent cells recorded from the same hemisphere or the nontransfected hemisphere. One potential issue when selecting the proper negative control
for this experiment is whether the lack of detectable YFP expression in the transfected
hemisphere can be used as an unambiguous selection criteria for untransfected
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neurons. To examine this issue we compared the ability of BaCl 2 100µM, a well
established Kir2.1 channel blocker, to reduce the Kir2.1-induced outward current
between YFP-expressing and non expressing close neighboring pyramidal cells within
the same hemisphere. Figure 2A shows holding current from individual cells (in voltage
clamp configuration, -60mV) before (open circles) and after BaCl 2 application (black
circles). Red bars indicate the average with standard error for each column. When
comparing non-YFP (left panel) with YFP-expressing cells (center panel) from the same
transfected hemisphere, we observed a significant reduction in the BaCl 2-induced
inhibition of the Kir2.1-mediated outward current. However, when comparing non-YFP
expressing cells from the transfected hemisphere with pyramidal cell from the
contralateral non-transfected hemisphere (right panel) we also found a significant
difference in BaCl2-induced inhibition between them despite the fact that both groups
could have been classified as “untransfected controls”. Figure 2B depicts the average
BaCl2-induced inhibition at cells from ipsilateral non-YFP, ipsilateral YFP and
contralateral cells (BaCl2-induced inhibition: non-YFP/ipsilateral: 96.58 ± 16.74 pA; YFPpositive/ipsilateral: 161.91 ± 14.30 pA; non-YFP/contralateral: 58.041 ± 10.19 pA). This
result indicates that non-YFP expressing cells from the transfected ipsilateral
hemisphere cannot be used reliably as “non-transfected control” cells and therefore
might not be the best negative control for this experiment. For this reason, we compared
YFP-expressing cells from the transfected ipsilateral hemisphere with cells matched for
location from the contralateral untransfected side as negative control for in utero
electroporation transfection experiments. These results validate the

in utero

16

electroporation transfection system as a suitable tool to transfect plasmids into specific
layers within the prefrontal cortex and identified suitable control cells.
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utero electroporation effectively transfects layer II/III pyramidal cells from cingulate
cortex. Test of YFP/Kir2.1 co-transfection as a marker for transfected and untransfected cells
following in utero electroporation. A. Cells were held at -60mV and 100µM barium was
administered to block standing Kir2.1 currents. Individual Kir2.1 currents recordings before and
after barium administration from ipsilateral non-YFP expressing controls (left panel), ipsilateral
YFP-expressing cells (center panel) and non-transfected location-matched cells from
contralateral hemisphere (right panel). B. Averaging of barium-induced inhibition of Kir2.1
currents recorded from ipsilateral non-YFP expressing (gray bar), ipsilateral YFP-positive (green
bar) and untransfected cells from contralateral hemisphere (open bar). These results do not
support the idea that non-YFP pyramidal cells of the transfected side could be used as controls
for transfected YFP-positive cells.
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As illustrated in Fig 3, knockdown of hippocalcin resulted in a significant reduction in the
amplitude of IsAHP in pyramidal cells. Figure 3A depicts representative traces of I sAHP
recorded from an YFP-expressing cell from the ipsilateral transfected hemisphere
(green trace) and a control cell matched for location from the contralateral side (black
trace). Insert shows DIC (upper panel) and fluorescence (lower panel) images of a slice
from a P15 mice transfected with YFP/shRNA-hippocalcin depicting both transfected
(left) and untransfected (right) hemisphere. Figure 3B summarizes I sAHP amplitudes
recorded from individual YFP-positive cells from the transfected side compared to
pyramidal cells matched for location on the opposite non-transfected side. The
corresponding IsAHP amplitude values were: control 27.16 ± 4.6 pA; shRNA hippocalcin
9.06 ± 2.5 pA. Red bars, average and standard error.
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Figure 3. siRNA hippocalcin knockdown reduces IsAHP amplitude. A. Superimposed traces
illustrating IsAHP recorded from shRNA/YFP transfected (green) and contralateral untransfected
control (black) mouse pyramidal cells. Inset, cingulate cortex (transfected and untransfected
hemispheres) in a living slice imaged using DIC (upper panel) and fluorescence (lower panel).
Calibration bar = 100µm. B. Summary plot depicting the IsAHP amplitude in 5 shRNA/YFP
transfected and 9 position matched untransfeceted cells from the contralateral hemisphere.
*p<0.05
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To corroborate the knockdown of hippocalcin after in utero YFP/shRNA-hippocalcin
transfection we proceeded to do an immunohistochemical analysis on slices from
transfected mice. Figure 4A shows the ipsilateral hemisphere of a brain slice obtained
from a P15 mouse transfected with YFP/shRNA-hippocalcin. YFP-positive cells are
shown in green, while cells expressing hippocalcin are shown in red. A drawing of the
transfected hemisphere depicting the cingulate cortex where the product of the
transfection appears is shown in the insert. Due to the restricted level of transfection by
in utero electroporation, only a limited number of cells will express the shRNAhippocalcin at the cortex. To better appreciate the knocking down of hippocalcin we
analyzed hippocalcin expression on YFP-positive cells. Figure 4B shows magnified
views of cingulate cortex from figure 4A. YFP-positive cells (white arrows) were single
identified by fluorescence (left panel). By switching color channels, the presence of
hippocalcin (middle panel) was evaluated on the same previously targeted cell. In this
set of pictures, we could appreciate that there was no hippocalcin-related fluorescence
in the YFP-positive cells, corroborating the knocking down of hippocalcin in the cells
transfected with YFP/shRNA-hippocalcin, while consistent hipoocalcin expression could
be observed in most of the non-YFP expressing cells. Merged images (right panel),
further corroborate this observation. These results, confirm the knockdown of
hippocalcin on layer II/III pyramidal cells by transfection of a pool of shRNA-hippocalcin
through in utero electroporation and support idea that hippocalcin is an important
contributor for the development of IsAHP in pyramidal cells of the prefrontal cortex.
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Figure 4. Knockdown of hippocalcin expression by electroporation of shRNAs directed
against hippocalcin in the cerebral cortex. A. Low magnification confocal image illustrating
hippocalcin (red) and YFP immunoreactivity (green) in the anterior cerebral cortex. Image
depicts a mosaic built from multiple contiguous images obtained at single optical plane.
Calibration bar: 500µm. B. Close-up images depicting three subregions within image A. Notice
that strongly YFP immunoreactive cells (arrows) generally express little if any hippocalcin. A rare
exception is denoted by the uppermost arrow in the third row of images to illustrate that codetection of YFP and hippocalcin in the green and red channels is possible. Calibration bar:
100µm. Antibodies: rabbit α-hippocalcin (Abcam ab24560) and rabbit α-GFP (Invitrogen,
A11122).
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One potential limitation of this knockdown experiment is that hippocalcin has been
suggested to act as a sensor for neuronal activity (Amici et al., 2009) and thus
suppressing its expression could result in homeostatic changes in neuronal excitability.
Any homeostatic change, however, can be expected to be minimized when hippocalcin
is acutely expressed. Therefore we transfected hippocalcin into pyramidal cells in
cortical slices maintained in organotypic cultures and assessed its effect on I sAHP using
paired recordings from neighboring transfected and untransfected pyramidal cells
(Beique et al., 2007;Yan et al., 2009). As illustrated in Fig 5, expression of hippocalcin
(green trace) resulted in a large increased in I sAHP amplitude that was accompanied by a
significant slowing of the decay kinetics of this aftercurrent (inserts Fig 5A and 5B)
(p<0.05). These loss of function and overexpression experiments indicate that
hippocalcin is an important protein involved in the regulation of the amplitude of I sAHP in
cortical pyramidal cells.

A

B 200

Scaled

1s

1s

IsAHP amplitude, pA

50 pA

150

T1/2 (hippocalcin), sec

23

5
4
3
2
1
0

0

1

2

3

4

5

T1/2 (control), sec

100

50

0

Control hippocalcin

Figure 5. Hippocalcin overexpression greatly increases IsAHP amplitude. A. Superimposed
traces depicting IsAHP recorded in a pair of pyramidal cells overexpressing hippocalcin (green
trace) and neighboring untransfected (black trace) from rat organotypic slices. Inset, same
recordings scaled to emphasize the change in the time course of I sAHP. B. Plot summarizing the
effects of hippocalcin expression on the amplitude and rate of decay (insert) of I sAHP for each cell
pair tested in this experiment. The half decay graph depicts only 11 cell pairs because it was not
possible to estimate the half decay for IsAHP in one of the control cells.
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The only partial inhibition of I sAHP by suppression of hippocalcin expression described by
Tzigounis (Tzingounis et al., 2007) raised the possibility that other members of the NCS
protein family could act in conjunction with hippocalcin as calcium sensors for I sAHP.
Hippocalcin shares considerable sequence homology with the NCS protein neurocalcinδ and VILIP-3 and previous studies have suggested this proteins may form a
functionally distinct subfamily of visinin-like proteins (Braunewell and Klein-Szanto,
2009;Burgoyne, 2007). Therefore, we next proceeded to transfect neurocalcin-δ, a close
homolog of hippocalcin (91% amino acid identity), and examined its effect on I sAHP. As
illustrated in figure 6A1, expression of neurocalcin-δ (green trace), like hippocalcin,
resulted in a large increase in IsAHP amplitude comparing to untransfected control
neighboring cells (black trace)(Fig 6A 1, insert; IsAHP amplitude, control: 56.68 ± 9.71 pA;
neurocalcin-δ: 98.69 ± 10.052 pA). Analysis of paired recordings corroborates this result
(Figure 6A2). Similarly as with hippocalcin, cells transfected with neurocalcin-δ showed a
slower IsAHP kinetic (Figure 6A3) (p<0.05). In contrast, transfection of VILIP-2, a more
distant member of the hippocalcin subfamily of NCS proteins (<70% amino acid identity)
had no effect on either IsAHP amplitude or decay kinetics (Figures 6B1, B2 and B3; IsAHP
amplitude, control: 52.306 ± 15.51 pA; VILIP-2: 48.48 ± 11.97 pA; p=0.85). Combined
these results indicate that I sAHP can be regulated by at least two members of the visininlike subfamily of NCS proteins.
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Figure 6. Neurocalcin-δ, but not VILIP-2 increase the amplitude and prolong duration of
IsAHP. A1. Superimposed traces of IsAHPs recorded from a cortical pyramidal cell transfected with
neurocalcin-δ (green) and from its neighboring untransfected control (black) in the same
organotypic slice. Inset, summary plot illustrating the effect of neurocalcin-δ on IsAHP amplitude in
8 cell pairs. *p<0.05. A2 and A3. Graphs illustrating the effects of neurocalcin-δ expression on
the amplitude (A2) and rate of decay (A3) of IsAHP for each cell pair tested in this experiment. The
half-decay for only 7 cell pairs is depicted in A 3 because it was not possible to estimate its value
for one of the control cells. A3, insert. Scaled traces from A1 to illustrate the slower time course
of neurocalcin-δ enhanced IsAHP. B1. Superimposed traces of IsAHPs recorded in cortical pyramidal
cells transfected with VILIP-2 (green) and a neighboring untransfected control cell (black). Inset,
summary graph depicting IsAHP amplitude in control cells and in cells transfected with VILIP-2. B2
and B3. Graphs illustrating the effects of VILIP-2 on the amplitude (B 2) and rate of decay (B3) of
IsAHP for each pair tested in this experiment. n=5 cell pairs tested. p=0.49
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NCS proteins sensitivity to calcium
Hippocalcin and neurocalcin-δ are expressed in the cerebral cortex in a roughly
overlapping pattern suggesting coexpression at the cellular level (Figure 7, extracted
from Allen Brain Atlas). Previous work has suggested that two or more NCS proteins
exhibiting different calcium affinities may work in tandem to extend the dynamic range of
calcium sensing (Burgoyne, 2007). Thus, we considered the possibility that hippocalcin
and neurocalcin-δ could sense different calcium concentrations to activate I sAHP. To test
this idea we examined the apparent calcium sensitivity of I sAHP under controlled calcium
influx conditions after transfection with either hippocalcin or neurocalcin-δ. As illustrated
in figure 8, hippocalcin and neurocalcin-δ, but not VILIP-2 (figures 8A, 8B and 8C
respectively), produce rightward shifts in the apparent calcium sensitivity of I sAHP.
Despite the apparently increase of sensitivity to calcium between untransfected cells
and cells transfected with hippocalcin or neurocalcin-δ, there was no significantly
difference in the calcium-sensitivity curves between hippocalcin and neurocalcin-δ
(Figure 8D). These results are inconsistent with the idea that hippocalcin and
neurocalcin-δ have different calcium affinities in order to transduce different
concentration of calcium, thus raising the possibility of differential expression of these
NCS proteins will depend on the cell type.
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Figure 7. Hippocalcin and neurocalcin-δ mRNA distribution in the medial prefrontal
cortex. Images are from the Allen Mouse Brain Atlas (Allen Institute for Brain Science, Lein et
al., 2007). Hippocalcin: Detail from Hpca_376 (position: 9400). Neurocalcin-δ: Detail from
Ncald_386 (position: 9650). Calibration bar: 1mm.
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Figure 8. Effect of hippocalcin, neurocalcin-d and VILIP-2 on the apparent calcium
sensitivity of IsAHP. Graphs depicting normalized hippocalcin (A), neurocalcin-δ (B) and VILIP-2
(C) -enhanced IsAHP amplitudes plotted against step voltage recorded on voltage-clamp
configuration. D. Plot depicting IsAHP against step voltage curves from hippocalcin and
neurocalcin-δ-enhanced IsAHP. The apparent calcium sensitivity curves were almost
superimposable. Hippocalcin, n=15 cell pairs; neurocalcin-δ, n=6 cell pairs; VILIP-2, n=4 cell
pairs.
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Neuromodulation of NCS-enhanced IsAHP
Little is known at the present time about the molecular identity of the channels carrying
IsAHP. This makes it difficult to unambiguously determine whether hippocalcin and
neurocalcin-δ facilitate the same channels mediating the native current. Previous
studies have shown that one of the defining characteristics of I sAHP is its inhibition by
neuromodulators acting through GPCRs coupling to heterometric G proteins of the Gαs
or Gαq/11 types (Andrade and Nicoll, 1987b;Nicoll, 1988). Therefore, we next examined
whether the NCS-enhanced IsAHP retains this sensitivity to neuromodulators acting via
Gαq/11. We focused on this signaling cascade because, under our recording conditions,
this modulation was more robust and reliable than that induced by receptors signaling
through Gαs.
Previous studies have shown that carbachol inhibits I sAHP in pyramidal cells of the
cerebral cortex by acting on muscarinic M 1/M3 receptors (Gulledge et al., 2009). At a
biochemical level these receptors activate Gαq/11 and PLCβ leading to the breakdown of
PtdIns(4,5)P2 (Kim et al., 1997; Yan et al., 2009). We first tested whether carbachol
indeed inhibited IsAHP through activation of Gαq/11 and PLCβ cascade. As illustrated in
figure 9A-B, the ability of carbachol to inhibit I sAHP was blocked by the expression of the
carboxy tail of PLCβ1 fused to GFP (PLCβ-ct), a dominant negative construct previously
shown to block Gαq/11 signaling in central and peripheral neurons (Kammermeier and
Ikeda, 1999;Yan et al., 2009). In addition, the carbachol-dependent inhibition of I sAHP was
also greatly reduced in animals where PLCβ1 (Fig 9C), the predominant PLCβ isoform
expressed in the cerebral cortex, has been genetically deleted (Kim et al.,
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1997;Watanabe et al., 1998). These results indicated that carbachol inhibits I sAHP in
cortex through Gαq/11 and, at least in part, through PLCβ1. To examine the sensitivity of
NCS-enhanced IsAHP to inhibition by Gαq/11 signaling we transfected pyramidal cells with
hippocalcin or neurocalcin-δ and again examined the effects of carbachol over I sAHP. As
illustrated in figure 10, administration of carbachol 30µM inhibited the IsAHP in a manner
that was not statistically different from untransfected controls, thus suggesting that the
NCS-enhanced IsAHP retain its ability to be inhibited by neuromodulators acting via Gαq/11
and PLCβ. These set of experiments confirm the nature of NCS-enhanced I sAHP, thus
highlighting the role of NCS in the development of I sAHP in pyramidal neurons of the
prefrontal cortex.
The previous results have shown that visinin-like NCS proteins accomplish a relevant
role in the development of I sAHP and that the NCS-enhanced I sAHP present similar
modulatory properties as the native current. However, these results do not provide a
hypothesis concerning the mechanisms by which neurotransmitters inhibit this current.
One possible explanation comes from the ability of several neuromodulators, including
carbachol, to activate Gαq/11/PLCβ1 pathways as previously demonstrated. This
activation leads to breakdown of PtdIns(4,5)P 2 in the membrane into diacyglicerol (DIG)
and IP3, therefore it is plausible that the reduction of PtdIns(4,5)P 2 levels at the plasma
membrane as a consequence of G protein-couple receptor activation would be a
conserved mechanism for IsAHP inhibition. This idea proposes a requirement of
membrane PtdIns(4,5)P2 in the plasma membrane for I sAHP development. The following
experiments aim to further investigate this hypothesis.
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Figure 9. Carbachol inhibits I sAHP through Gαq/11/PLCβ1 pathway. A. Superimposed traces
depicting the effect of carbachol (30µM) on IsAHP recorded from pyramidal cells transfected with
the Gαq/11 dominant negative PLCβ1-ct or from a neighboring control cell. Control = black trace;
carbachol = red trace. B. Summary plot illustrating the effect of carbachol in control and PLCβ1ct transfected pyramidal cells. *p<0.001. C. Summary plot depicting the effect of carbachol on
IsAHP amplitude recorded from pyramidal cells in slices derived from wild type and PLCβ1
knockout mice. *p<0.001.
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Figure 10. Carbachol inhibits native and NCS-enhanced I sAHP. A. Superimposed traces
recorded from pyramidal cells transfected with hippocalcin or from untransfected neighboring
control cells. Control = black trace; carbachol = red trace. B. Summary graph plotting the
carbachol-induced inhibition of IsAHP in 7 control cells (open circles), 7 cells transfected with
hippocalcin (black circles) and 5 cells transfected with neurocalcin-δ (gray circles). Note that
even in slices derived from young animals carbachol was able to induce a slow
afterdepolarization (Yan et al., 2009), which resulted in a fractional inhibition of I sAHP bigger than
1.
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CHAPTER 4
Involvement of PtdIns(4,5)P2 in the triggering of IsAHP
IsAHP rundowns upon prolonged whole cell recordings
Besides being activated by calcium influx, one of the most prominent features of I sAHP
recorded in whole cell configuration is that it runs down over prolonged periods of time.
Under our recording conditions I sAHP decreases by nearly 80% within one hour of
recording without any obvious change in its time course (Figure 11A 1). One may argue
that cell integrity may be compromised during prolonged whole cell recording and that
this could be a factor altering ion channels behavior, therefore affecting the activation of
IsAHP. To test this, in voltage-clamp configuration, we measured the holding current
together with IsAHP to monitor cell integrity. Our results indicate that I sAHP rundown was not
linked to a detriment of cell integrity since the holding current remained stable through
all the recording period even though I sAHP runs down dramatically (Figure 11A2).
Since IsAHP has been described as a calcium-activated current, it is plausible to conceive
that this rundown effect could simply reflex a decrease in calcium influx secondary to
the rundown of calcium currents. We first assessed this possibility by examining the
rundown of ImAHP, a second calcium-activated potassium current carried by K Ca2.X (SK)
channels that is also expressed in pyramidal cells (Villalobos et al., 2004). As illustrated
in figure 11B, ImAHP exhibits little rundown over one hour of recording, a time frame
during which IsAHP undergoes near complete rundown. I sAHP and ImAHP exhibit partly
overlapping time courses and therefore, to reduce contamination in the measurement of
ImAHP for these experiments, we focused on pyramidal cells expressing small I sAHPs
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(insert Fig 11B). This suggested limited rundown of calcium currents and calcium influx
under our recording conditions. Finally, to independently assess changes in calcium
influx, in collaboration with Dr. Robert C. Foehring, we conducted calcium imaging
experiments while simultaneously recording I sAHP (Abel et al., 2004). As illustrated in
figure 10C, somatic and dendritic calcium transients remain stable over nearly an hour
of whole recording while I sAHP again exhibited very substantial rundown. These
experiments show a clear dissociation between the rundown of I sAHP and changes in
calcium transients and thus do not support the idea that the rundown of I sAHP is simply
secondary to the rundown of calcium currents.
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runs down upon prolonged whole-cell recording. A. IsAHP progressively runs down during
whole-cell configuration when recorded on a period longer than 15-20 minutes. A1.
Representative tracings showing IsAHP reduction over time. A2. Under our conditions, IsAHP runs
down to about 20% of its initial amplitude after 60 minutes of whole-cell recording. I sAHP rundown
does not correspond to changes in the holding potential of the cells as shown in the adjusted

36
holding current average plot. B. Rundown of the IsAHP is not associated with changes in
intracellular calcium influx. Time course plot of I mAHP amplitude recorded on whole-cell
configuration. Inset, representative traces depicting lack of rundown on ImAHP after 30 minutes of
whole-cell recording. C. Simultaneous IsAHP amplitude and intracellular calcium transients (at
apical dendrite or at the soma) showed no correlation between I sAHP rundown and intracellular
calcium levels. Top, representative traces of calcium transients recorded after 0, 10 and 30
minutes after breaking into the cell. Calcium transients are expressed as percentage of dF/F.
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Facilitating PtdIns(4,5)P2 biosynthesis protects IsAHP from rundown
This rundown effect seen on I sAHP is not unknown among ionic channel’s behavior. The
activity of a number of them, including several potassium channels, undergoes rundown
upon patch excision or protracted whole cell recording as a result of the progressive
loss of membrane PtdInd(4,5)P2 (Logothetis et al., 2007;Zhang et al., 2003). These
observations raised the possibility that the rundown of I sAHP observed in pyramidal
neurons of the prefrontal cortex could similarly involve loss of membrane PtdIns(4,5)P 2.
To test this idea, we took advantage of the previous demonstration that membrane
PtdIns(4,5)P2 levels can be effectively manipulated in intact cells by regulating its
synthesis and degradation (Li et al., 2005;Suh et al., 2006;Suh and Hille, 2002;Zhang et
al., 2003).
In a first set of experiments we facilitated PtdIns(4,5)P 2 biosynthesis by increasing the
availability of inositol, which is the obligatory starting substrate for the synthesis of
PtdIns(4,5)P2. In order to better appreciate the role of levels of inositol on the
development of IsAHP, we minimized the de novo inositol biosynthesis by reducing
extracellular glucose while maintaining intracellular ATP levels by including MgATP and
phosphocreatine in the intracellular recording solution. This maneuver slightly
augmented the rate of IsAHP rundown. To determine the effect of inositol we added myoinositol, a precursor of PtdIns(4,5)P2, to the intracellular recording solution (10-30mM)
and allowed it to diffuse into the pyramidal cells. As illustrated in Fig 12A, this
manipulation resulted in a significant protection of I sAHP from rundown as compared with
either cells recorded without myo-inositol or cells perfused with low-glucose extracellular
solution. Overall in this experiment I sAHP was found to decay to 48±6% of its initial
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amplitude within 20 minutes of continuous recording in the absence of inositol, but
remained at 87±5% of its initial amplitude in presence of myo-inositol. This protective
effect of inositol persisted through the end of the experiment (60 minutes, p<0.05). A
similar, albeit less robust, protection of I sAHP was obtained following addition of myoinositol to the extracellular media, a manipulation that relies on the ability of neurons to
efficiently take up inositol (Fisher et al., 2002).
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Figure 12. IsAHP rundown can be slowed down by addition of the inositol precursor myoinositol to the recording pipette. A. Time course plot depicting I sAHP amplitude rundown over
time with regular Ringer (solid line), low-glucose extracellular solution (gray circles) and myoinositol added to the recording pipette in low-glucose extracellular solution (open circle). Lowglucose extracellular solution was used to increase I sAHP rundown and thus highlight the role of
myo-inositol. B. To further corroborate the direct effect of myo-inositol on the reduction of I sAHP
rundown rate we proceeded to measure calcium levels simultaneously with I sAHP amplitude in
presence and absence of myo-inositol. B1. Picture showing a single cell filled with the calciumsensitive dye fura-2 in whole-cell configuration for simultaneous recording of I sAHP and calcium
levels. Bar scale = 22µm. B2. Measurement of intracellular calcium levels plotted as normalized
dF/F ratio showing no significant change in calcium concentrations upon addition of myo-inositol
(black square) to the recording pipette as compared with control cell recorded without inositol
(white squares). Inset, representative traces of calcium transients recorded at 0, 10 and 30
minutes after breaking into the cell, without and with myo-inositol in the recording pipette.
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While these results supported the idea that the rundown of I sAHP involved inositol
metabolism, it remained possible that inositol could protect I sAHP indirectly, i.e. by
increasing intracellular calcium influx. Therefore we again imaged intracellular calcium
transients as a function of time in presence and absence of myo-inositol added to the
intracellular solution (Fig 12B 1). As illustrated in figure 12B 2, we could not detect any
significant differences in calcium influx in response to addition of myo-inositol to the
intracellular solution. These results argued against an indirect effect on calcium entry
and pointed to a direct effect of inositol on the stability or maintenance of I sAHP.
Taking into consideration the results described above, it is plausible to conceive the idea
that IsAHP might be carried through a potassium channel doubly activated by calcium and
PtdIns(4,5)P2 at the plasma membrane. One way to explain the above results would be
that when the concentration or availability of this phospholipid gets reduced, the activity
of these channels would be also diminished and so would I sAHP amplitude. On the other
hand, based on the same premises, if PtdIns(4,5)P 2 concentration gets increased at the
plasma membrane, one could expect that I sAHP amplitude might be augment as well. To
test this idea, we perform a series of experiments were we overexpressed the
PtdIns(4,5)P2 synthetic enzyme phosphatidylinositol 4-phosphate kinase (PIP5K) which
is thought to be responsible for the synthesis of most cellular PtdIns(4,5)P2 (Van &
Divecha, 2009). In mammals, PIP5K activity is mediated by three alternatively spliced
isoforms (Iα, Iβ and Iγ), with the gamma isoform showing the strongest expression in
neurons (Giudici et al., 2004; Akiba et al., 2002). Therefore, for these experiments we
used biolistic transfection (particle mediated gene transfer or “gene gun”) to transfer into
cortical pyramidal cells two EGFP-tagged alternative spiced isoforms of PIP5Kγ
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(PIP5Kγ90 or PIPK5γ93; Giudici et al., 2006). These experiments were conducted in
cortical slices in organotypic culture and we used paired recordings to examine I sAHP in
transfected and neighboring untransfected cells to control for cell location and slice
history. Biolistic transfection of either of these enzymes into pyramidal cells resulted in a
strong expression of the fused protein, as visualized by the EGFP fluorescence, which
localized predominantly to the plasma membrane especially in dendritic processes
(Figure 13A). Surprisingly, expression of these enzymes had no detectable effect on
IsAHP amplitude at early times following whole cell access (Figure 13B); however, it
greatly protected IsAHP from rundown (Figure 13C 1 and 13C2). Overall in these
experiments IsAHP was found to decay to 46±6% (n=8) of its initial amplitude in control
untransfected cells within 30 minutes of recording but only to 82±6% (n=7) of its initial
amplitude in PIP5K transfected neurons (p<0.05) and this protective effect persisted
until the end of the experiment (p<0.05). Combined, these experiments indicated that
increasing PtdIns(4,5)P2 biosynthesis did not increase IsAHP amplitude but protected it
from rundown, thus rejecting the hypothesis of a direct involvement of PtdIns(4,5)P 2 in
IsAHP activation and therefore suggesting the idea that PtdIns(4,5)P 2 could be an
essential component for IsAHP triggering.
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Figure 13. Facilitating PtdIns(4,5)P2 biosynthesis reduces IsAHP rundown. A. Picture
showing expression of PIPK5γ90-EGFP fusion protein plus m-cherry into pyramidal cells of
prefrontal cortex. PIPK5γ90 can be seen expressed in plasma membrane and dendritic process
while m-cherry distributes homogeneously through the entire cell, mostly in the soma. B. Graph
depicting average IsAHP amplitude recorded from cells transfected with PIPK5 and untransfected
neighboring control. Top panel, representative traces showing I sAHP obtained from control (black)
and PIPK5γ90 expressing pyramidal cells. C1. Representative tracings depicting reduction of
IsAHP rundown on cell overexpressing PIPK5. Traces were obtained from pair recordings at 5 and
30 minutes after break into the cell. C2. Time course plot of normalized I sAHP amplitudes from
PIPK5-expressing cells (gray circles) and control untransfected neurons (open circles). Arrows
indicate the time at which traces from C1 were obtained.

45

Inhibiting PtdIns(4,5)P2 biosynthesis accelerates the rundown of IsAHP
If the functional expression of I sAHP depends on membrane PtdIns(4,5)P2, then inhibiting
the synthesis of this phosphoinositide, reducing its concentration or availability at the
plasma membrane should accelerate the rundown of I sAHP. To test this idea we first used
the lipid kinase inhibitor wortmannin, a well established phosphatidylinositol 4-kinase
(PIK4) inhibitor, to inhibit PtdIns(4,5)P2 synthesis (Meyers and Cantley, 1997;Nakanishi
et al., 1995). As illustrated in figure 14A, bath application of wortmannin (10µM)
significantly accelerated the rundown of I sAHP (middle panel) as compared with control
cells (top panel) and resulted in the near complete disappearance of I sAHP in the course
of the experiment. Under control conditions, I sAHP rundown to 56±6% of its initial value
after 60 minutes but to 11±1% of its initial value in presence of wortmannin (p<0.05, Fig
14B). Within the phosphoinositide synthetic pathway wortmannin not only inhibits the
synthesis of PtdIns(4,5)P2 by inhibiting PIK4 but it has been reported to also inhibits
phosphoinositide-3 kinase (PI3K). Therefore, to control for this activity we tested the
effect of the selective PI3K inhibitor LY 294002 on the rundown of I sAHP. As illustrated in
figure 14A (lower panel) and 14C, administration of LY 294002 (10µM) had no
significant effect on the rundown of I sAHP when compared with control cells and the
amplitude of IsAHP in control and LY 294002 treated sliced did not differ significantly after
60 minutes of recording (Control: 52.64 ± 3.23 %, LY 294002: 43.22 ± 6.035 %, p=0.76;
Figures 14C and 14D). In order to rule out any secondary effect of wortmannin over
calcium transients that could affect IsAHP, we again simultaneously recorded IsAHP and
imaged calcium transients in response to depolarizing voltages steps in the presence
and absence of wortmannin. In these experiments, wortmannin accelerated the
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rundown of IsAHP but had little effect on the amplitude of the calcium transients (not
shown) supporting the idea that PtdIns(4,5)P 2 could play a role in the development of
IsAHP.
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Figure 14. Myo-inositol effect over I sAHP rate of rundown can be blocked by PI4K
inhibition. A. Representative traces depicting increased IsAHP rate of rundown upon selective
inhibition of PI4K. Top panel, control cell showing reduced rundown after 60 minutes of
continuous whole-cell recording (all measurements done with myo-inositol 30mM added to the
recording pipette); medium panel, wortmannin applications increases I sAHP rundown to the extent
of almost completely abolish its amplitude; bottom panel, PI3K selective inhibitor LY 294002
does not affect IsAHP rate of rundown. B. time course plot of normalized IsAHP amplitude with and
without wortmannin (10µM) added to the bath. Control, n=6; wortmannin, n=5. C. Time course
plot of normalized IsAHP with and without LY 294002 (10µM). D. Plot of normalized IsAHPs recorded
in control conditions (white bars), with wortmannin (black bar) and with LY 294002 (gray bar)
measured after 50 minutes of continuous whole-cell recording.
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While these experiments support the idea that the functional expression of I sAHP depends
on PtdIns(4,5)P2, they are limited due to concerns about selectivity of wortmannin. As
an alternative we sought for non-pharmacological ways to reduced either the levels or
availability of membrane PtdIns(4,5)P 2. Previous experiments have successfully
reduced membrane PtdIns(4,5)P2 levels by expressing 5-phosphatases (Li et al., 2005).
Therefore, we used particle-mediated gene transfer to express the mouse 5phosphatase II (Inpp5b) in pyramidal cells. This phosphatase was chosen because,
among 5’ phosphatases, this particularly isoform is well expressed in the brain (Janne et
al., 1998), including the cerebral cortex (Allen Brain Atlas). To test the effect of Inpp5b
on IsAHP we again conducted paired recordings from transfected and neighboring
untransfected pyramidal cells in organotypic slices. All experiments were conducted 2448 hrs after transfection. As shown in figured 15A, expression of Inpp5b resulted in a
significant reduction of IsAHP amplitude (p<0.05). In contrast, I mAHP was not affected by
expression of Inpp5b in pyramidal cells (insert).
Previous studies have also successfully reduced the availability of membrane
PtdIns(4,5)P2

using

sequestering

strategies,

which

effectively

make

this

phosphoinositide unavailable to interact with the channel of interest (Li et al.,
2005;Nakanishi et al., 1995). Therefore we also examined the effect of sequestering
PtdIns(4,5)P2 using the PH domain of phospholipase C-δ1 fused to GFP (GFP-PH PLCδ1)
(Stauffer et al., 1998). Previous studies have shown the effectiveness of this construct
for binding and sequestering membrane PtdIns(4,5)P 2 (Li et al., 2005;Nakanishi et al.,
1995). As depicted in figure 15B, expression of GFP-PH PLCδ1 in pyramidal cells again
resulted in a significant reduction of the amplitude of I sAHP without any mayor alteration
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on ImAHP amplitude. Combined these results indicate that the functional expression of
IsAHP depends on the availability of membrane PtdIns(4,5)P 2.
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Figure 15. Presence of PtdIns(4,5)P2 in the plasma membrane is a key factor for the
development of IsAHP in pyramidal neurons of the prefrontal cortex. A. Overexpression of
the phosphatidylinositol bis-phosphate 5B (InPP5B) vector tagged with m-cherry fluorescent
protein into organotypic brain slices reduced I sAHP amplitude in positive-transfected fluorescent
cells. Top panel, representative traces of InPP5B transfected and non-transfected control cell.
Bottom panel, averaged IsAHP amplitudes for InPP5B and non-transfected controls. *p<0.05.
Insert, averaged ImAHP amplitude obtained from InPP5B and non-transfected control
demonstrating IsAHP-dependence on PtdIns(4,5)P2 at the plasma membrane. B. Transfection of
the green fluorescent protein-tagged plekstrin homology domain of PLCδ1 (GFP-PHPLCδ1) into
organotypic brain slices significantly reduced I sAHP amplitude as compared with non transfected
cells. top panel, representative traces depicting double whole-cell recordings of a GFP-PH PLCδ1
transfected cell and a nearby non-transfected control cell. Bottom panel, quantification of
averaged IsAHP amplitude on GFP-PHPLCδ1 transfected and non-transfected control cells. *p<0.05.
Inset, averaged ImAHP amplitude from GFP-PHPLCδ1 and neighboring non-transfected control cells.
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Increasing membrane PtdIns(4,5)P2 facilitates the ability of calcium to activate IsAHP
Increasing PtdIns(4,5)P2 did not augmented IsAHP amplitude, thus ruling out the
hypothesis of a direct role of PtdIns(4,5)P 2 in activating the channels underlying I sAHP;
therefore, we sought for an alternative hypothesis to explain these results. One possible
interpretation is that PtdIns(4,5)P 2 plays a permissive role for the expression of I sAHP in a
manner analogous to Kir or Kv7 potassium currents. It has been previously
demonstrated that these channels require of PtdIns(4,5)P 2 in the plasma membrane for
their activation (Li et al., 2005;Zhang et al., 2003). Furthermore, Kv7 channels are
known to be inhibited when PtdIns(4,5)P 2 levels are reduced (Suh et al., 2006). Thus, in
analogy with these channels’ properties for activation, altogether these evidences allow
us to propose PtdIns(4,5)P2 as an essential component for I sAHP activation, although in
this case, IsAHP would be additionally gated by calcium. Alternatively, previous studies
have shown that potassium channels vary widely in their affinity for PtdIns(4,5)P 2 and
that at least some classes of potassium channels are not fully saturated by resting
levels of

PtdIns(4,5)P2 (Delmas and Brown, 2005;Du et al., 2004;Li et al., 2005).

Furthermore, there is also growing evidence that the local availability of PtdIns(4,5)P 2 is
highly regulated and that one factor that regulates this availability is calcium
(Hilgemann, 2007;McLaughlin and Murray, 2005). Therefore an alternative interpretation
for the observation that IsAHP is dependent on PtdIns(4,5)P2 is that IsAHP represents a
transient calcium-induced increase in the availability of PtdIns(4,5)P 2 which in turn
activates PtdIns(4,5)P2-dependent potassium channels. To distinguish between these
two possibilities we examined the calcium sensitivity of I sAHP under calcium influx-
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controlled conditions and after increasing membrane PtdIns(4,5)P 2 by overexpression of
PIP5K.
To examine the calcium sensitivity of I sAHP we used depolarizing steps of varying
durations to elicit graded increases in calcium entry. As previously observed by others
(Gerlach et al., 2004;Kim et al., 1997), increasing calcium influx is linked to increases in
IsAHP. Another way to elicit increasing I sAHP is by augmenting the amplitude of the
depolarizing step while holding its duration constant (see figure 1C). Expression of
either PIPKγ90 or PIPKγ93 resulted in a large increase in the apparently sensitivity to
calcium when using depolarizing steps shorter than 10 ms (Figure 16A), which elicited
little or no IsAHP under control conditions but a robust, graded I sAHP in cells transfected
with either PIPK5 isoform. A similar results could be observed when depolarizing steps
ranged from 10-100 ms, where cells transfected with PIPK5 reached a maximum I sAHP
amplitude at steps as short as 20 ms, while untransfected controls did it at steps over
80 ms (Figure 16B). Continued increases in the duration of the depolarizing pulses did
not further elicited larger I sAHPs; as seen in figure 16C, depolarizing steps longer than
100 ms did not increased I sAHP amplitudes in either PIPK5 or untransfected cells. These
results are inconsistent with the idea that PtdIns(4,5)P 2 plays a permissive role for the
functional expression of IsAHP and instead point to a role of PtdIns(4,5)P 2 in the gating of
IsAHP, downstream from calcium influx.
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Figure 16. PIPK5 overexpression increases IsAHP calcium sensibility. A. Short voltage steps
of durations between 1 to 10 milliseconds elicited small I sAHP amplitudes in control nontransfected pyramidal cells (left panel). When similar voltage steps were applied to PIPK5expressing cells, IsAHP amplitudes were considerable greater (right panel). A1. Plot depicting
average of currents (mean of 50 points, ms) elicited in control and PIPK5-expressing pyramidal
cells. IsAHPs were elicited by depolarizing steps from -60 to +20mV of 0, 1 and 9 milliseconds of
duration. A2. Averaged IsAHP amplitude of non-transfected controls (black circles) and PIP5Kexpressing cells (open circles) elicited at various depolarizing step lengths. B. Increasing
depolarizing step duration augmented IsAHP amplitude in control untransfected cell (black circles);
on the other hand, on PIPK5-expressing cells (open circles), I sAHP amplitudes were not
significantly increased reaching its maximum amplitude at depolarizing steps as short as 20
milliseconds. C. Continuing increasing depolarizing step durations did not further increased I sAHP
amplitude in neither non-transfected controls (black circles) nor PIP5K-expressing cells (open
circles). Depolarizing steps from 100 to 600 milliseconds did not elicited greater IsAHP amplitudes.
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CHAPTER 5
Conclusions
Despite the importance and efforts involved in clarifying the identity of the ion channels
carrying IsAHP and the mechanisms by which this current is activated by calcium,
relatively little is still known about both of these questions. Several studies have helped
to describe the intracellular signaling of I sAHP currents in various systems, however, the
channels underlying this current and the mechanisms of activation leading to its
appearance are still a very intricate puzzle. As an example of how intricate the study of
this current has been, not even one of its most established features, its close
relationship to calcium influx, is yet understood. Thus, exactly how calcium influx
activates the potassium channels underlying I sAHP remains an open question. The
simplest explanation for this inquiry would involve calcium influxes directly activating
IsAHP, however, a number of researchers have questioned the idea of calcium transients
evoked during action potentials having a direct role in the activation of this current. The
differences between calcium kinetics and I sAHP activation (Abel et al., 2004) led to the
idea that a series of accessory proteins could mediate I sAHP activation, an the later
observations made by Tzingounis (Tzingounis et al., 2007) that deletion of hippocalcin
resulted in a reduction of IsAHP amplitude in hippocampal pyramidal cells further
supported this hypothesis. However, the proposing of hippocalcin as the calcium sensor
for IsAHP, while making much needed fresh inroads into our understanding of this current,
raised a number of important mechanistic questions (Brown et al., 2007;Tzingounis et
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al., 2007). The restricted expression of hippocalcin in the brain, and the partial
suppression of IsAHP observed in the hippocalcin knockout mouse, questioned whether
hippocalcin alone could account for the calcium sensitivity of I sAHP (Brown et al., 2007).
In the current work we used loss of function and overexpression approaches to show
that hippocalcin indeed regulates IsAHP in the cerebral cortex and we could also establish
that neurocalcin-δ, a closely related visinin-like NCS protein, also mediates IsAHP. These
results solve inconsistencies surrounding the identification of hippocalcin as the sole
calcium sensor for IsAHP and point to a broader role of NCS protein, specifically from the
visinin-like subfamily, in the regulation of this current.
The original suspicion that hippocalcin may not be the only calcium sensor for I sAHP was
grounded not only on the presence of a residual I sAHP in the hippocalcin knockout
mouse, but also in the observation that this residual I sAHP was relatively resistant to
inhibition by norepinephrine, acting through β-adrenergic receptors (Tzingounis et al.,
2007). This led Brown (Brown et al., 2007) to suggest that I sAHP may be gated through
two parallel branches exhibiting differential sensitivity to inhibition by norepinephrine. In
the current work we show that carbachol, known to act on M1 receptors, inhibits I sAHP in
cortical pyramidal neurons through Gαq/11/PLCβ1 pathway. Furthermore, we show that
the native, the hippocalcin- and neurocalcin-δ-enhanced IsAHPs, are all inhibited to a
comparable extent through this signaling cascade. These results suggest that the
Gαq/11/PLCβ1 signaling cascade does not distinguish between hippocalcin- or
neurocalcin-δ- gated IsAHP. However, these results do support the idea that hippocalcin
and neurocalcin-δ can both transduce calcium signals and activate a common channel
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leading to the activation of the native I sAHP, thus highlighting a broader role of NCS
proteins in the development of this current.
These results support the idea that of at least two distinct NCS proteins can act as
calcium sensors for IsAHP. The idea of having multiple proteins transducing calcium
signals might seem redundant if we take into consideration the possibility that two or
more of these proteins might be co-expressed in at least some cortical neurons. On
possible explanation would be that NCS proteins present different calcium affinities,
thus regulating a single molecular target and increasing the dynamic range of calcium
sensing (Burgoyne, 2007). In the current work we find that while both hippocalcin and
neurocalcin-δ slightly increase the apparent calcium sensitivity of I sAHP, within the limits
of this assay, the calcium sensitivity of these NCS-enhanced I sAHP are indistinguishable.
As such, these results are inconsistent with the idea that hippocalcin and neurocalcin-δ
sense different calcium concentrations when regulating I sAHP. Further studies examining
alternative hypothesis, such differential cell-type specific expression of these NCS
proteins, are clearly needed to clarify and understand this apparently redundancy.
The results presented in the present work support Tzingounis’ observations (Tzingounis
et al., 2007) and provide additional information leading to the hypothesis of a broader
action of NCS proteins on regulation of I sAHP. These results are consistent with the idea
that accessory proteins from the NCS family, specifically the visinin-like subgroup,
regulate the activation of IsAHP in pyramidal neurons of the prefrontal cortex. We also
show that hippocalcin and neurocalcin-δ not only increased IsAHP amplitude, but also its
calcium sensitivity, therefore supporting the idea that these NCS proteins sense calcium
as part of the gating of the I sAHP. Such interpretation is consistent with the results from
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previous studies showing that IsAHP follows the time course of cytoplasmic calcium (Abel
et al., 2004) and that hippocalcin shuttles from the cytoplasm to the membrane in
response to rises in intracellular calcium, and does so with a time course compatible
with a role in signaling I sAHP (Markova et al., 2008). However, exactly how these visininlike NCS proteins may function in the context of gating I sAHP remains still unclear, and the
manipulations used to date leave open the possibility of indirect effects on I sAHP
channels, for example the facilitation of intermediate steps in the gating process, or
more broadly, even adaptive changes in excitability.
Having established that visinin-like members of NCS protein family are important
molecules for the development of IsAHP, we then proceeded to investigate the role of
PtdIns(4,5)P2 in the gating or activation of this current. In the present work we show that
membrane PtdIns(4,5)P2 plays a key role in the functional expression and gating of I sAHP
in cortical pyramidal neurons. The first hint that I sAHP could be regulated by PtdIns(4,5)P 2
emerged from the observation that this current runs down upon prolonged whole cell
recording, a phenomenon that has been seen in other potassium currents, such as Kir
and Kv7 potassium currents, and has been shown to result from the depletion of
membrane PtdIns(4,5)P2. Here we show that I sAHP rundown could be suppressed by
manipulations that facilitate PtdIns(4,5)P 2 biosynthesis, such as increasing the
availability of the precursor for PtdIns(4,5)P 2 or expressing the synthetic enzyme PIP5K.
On the other hand, decreasing the levels or availability of membrane PtdIns(4,5)P 2 by
expressing a 5’ phosphatase to reduce its membrane concentration or expression of the
PH domain of PLCδ1 to sequester it, both resulted in profound suppression of I sAHP.
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One potential confound of the above experiments is that I sAHP is triggered by calcium
influx, and calcium channel activity itself has been shown to be dependent on
membrane PtdIns(4,5)P2. However changes in IsAHP were clearly dissociable from
changes in ImAHP, used as a physiological tool to monitor calcium levels, and calcium
transients imaged at the level of the soma and proximal dendrites. These results make
unlikely that the observed changes in I sAHP could be explained simply by changes in
calcium influx; rather, they suggest that the functional expression of I sAHP is directly
dependent on the availability of membrane PtdIns(4,5)P 2. These results also suggest
that, at least under our recording conditions, calcium currents are considerably more
resistant to reduction in membrane PtdIns(4,5)P 2 than IsAHP.
The results obtained from the experiments manipulating the levels of PtdIns(4,5)P 2 in
the membrane, indicate that the functional expression of I sAHP depends on the availability
of this phospholipid at the plasma membrane. Thus, I sAHP joins a growing list of ion
channels whose activity depends on the presence of membrane PtdIns(4,5)P 2 (Suh and
Hille, 2005). In fact, the strategies used in the current study to demonstrate the
involvement of PtdIns(4,5)P2 were pioneered in a series of now classic studies
addressing the regulation of Kir and Kv7 currents. The main difference is that previous
studies on isolated cells rely in part on the direct application of PtdIns(4,5)P 2 analogs, a
strategy that is not feasible in brain slices due to limited accessibility to the recorded
cell. This limitation notwithstanding, the combined results of the present study lead us to
conclude that IsAHP could be a PtdIns(4,5)P2-sensitive potassium channel.
But how is it that PtdIns(4,5)P 2 activates IsAHP? How does it correlate with the calciumactivated nature of I sAHP? The simplest interpretation would be that I sAHP is carried by a

60

calcium-activated potassium channel that also requires PtdIns(4,5)P 2 for its activity.
Alternative, it is also possible that calcium does not directly activate I sAHP but rather
could gate this current by transiently increasing the availability or concentration of
PtdIns(4,5)P2 in the vicinity of the IsAHP channels. In the present work we tested out these
possibilities. In one set of experiments we increased the levels of membrane
PtdIns(4,5)P2 through overexpression of PIPK5, the presumed rate limiting enzyme for
this phospholipids biosynthesis. Remarkably, expression of either of the two isoforms of
PIP5K failed to increased overall amplitude of I sAHP, which may have been expected if
PtdIns(4,5)P2 played a permissive role. Equally telling, neither did expression of PIPK5
occluded IsAHP, which could have been expected if IsAHP was simply gated by an increase
in membrane PtdIns(4,5)P2. Rather, increasing membrane PtdIns(4,5)P2 robustly
facilitated the ability of calcium influx to elicit I sAHP. These results indicate that
PtdIns(4,5)P2 regulates IsAHP downstream from the rise in intracellular calcium. However,
because the maximum amplitude of I sAHP was not changed, this facilitation is unlikely to
take place at the level of the channel itself (i.e. the effect is not merely permissive) but
rather on the ability of calcium to gate I sAHP. Although the exact mechanism underlying
this phenomenon is not revealed by the current experiments; it is possible to imagine
several possibilities. For example, calcium could gate I sAHP by transiently increasing the
local availability of PtdIns(4,5)P 2 to the sAHP channels by eliciting the translocation of
key PtdIns(4,5)P2 synthesizing enzymes to the membrane, or by locally increasing
PtdIns(4,5)P2 levels by forcing the dissociation of PIP modulins. Alternatively, increases
in PtdIns(4,5)P2 could facilitate the calcium gating of IsAHP by facilitating the docking of
NCS proteins at the membrane which in turn will activate sAHP channels. Support for
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this idea comes from the observations made by O’Callaghan (O'Callaghan et al., 2005).
In this work, the authors demonstrate a high affinity interaction of the myristoylation
motif of hippocalcin with PtdIns(4,5)P 2, supporting the idea that this phospholipids may
serve as recruiting spot for NCS proteins after calcium influx.
The results outlined above, while addressing the role of PtdIns(4,5)P 2 in the regulation
of IsAHP, also suggest a possible reinterpretation of the nature of I sAHP. A corollary from
these findings is that IsAHP may not be an unitary ionic current as usually understood but
rather may represent the macroscopic manifestation of a calcium-induced increase in
local PtdIns(4,5)P2 concentration that activates a varying and heterogeneous population
of PtdIns(4,5)P2 sensitive potassium channels, whose exact composition may depend
on the cellular context. In other words, I sAHP may not be so much a current, but the
embodiment of a biochemical gating mode. If this conjecture is correct, it would explain
many of the puzzling properties of this current including its extraordinary slow time
course, its anomalous dependence on intracellular calcium, and why its single channel
properties and molecular composition appear to be cell dependent.

62
REFERENCES

1. Abel,H.J., Lee,J.C., Callaway,J.C., and Foehring,R.C. (2004). Relationships between
intracellular calcium and afterhyperpolarizations in neocortical pyramidal neurons. J.
Neurophysiol. 91, 324-335.
2. Adams,P.R., Constanti,A., Brown,D.A., and Clark,R.B. (1982). Intracellular Ca2+ activates a
fast voltage-sensitive K+ current in vertebrate sympathetic neurones. Nature 296, 746-749.
3. Alger,B.E., and Nicoll,R.A. (1980). Epileptiform burst afterhyperolarization: calciumdependent potassium potential in hippocampal CA1 pyramidal cells. Science 210, 11221124.
4. Amici,M., Doherty,A., Jo,J., Jane,D., Cho,K., Collingridge,G., and Dargan,S. (2009). Neuronal
calcium sensors and synaptic plasticity. Biochem. Soc. Trans. 37, 1359-1363.
5. Andrade,R., and Nicoll,R.A. (1987a). Pharmacologically distinct actions of serotonin on single
pyramidal neurones of the rat hippocampus recorded in vitro. J. Physiol 394, 99-124.
6. Bai,J., Ramos,R.L., Ackman,J.B., Thomas,A.M., Lee,R.V., and LoTurco,J.J. (2003). RNAi reveals
doublecortin is required for radial migration in rat neocortex. Nat. Neurosci. 6, 1277-1283.
7. Beique,J.C., and Andrade,R. (2003). PSD-95 regulates synaptic transmission and plasticity in
rat cerebral cortex. J. Physiol 546, 859-867.

63
8. Beique,J.C., Imad,M., Mladenovic,L., Gingrich,J.A., and Andrade,R. (2007). Mechanism of the
5-hydroxytryptamine 2A receptor-mediated facilitation of synaptic activity in prefrontal
cortex. Proc. Natl. Acad. Sci. U. S. A 104, 9870-9875.
9. Benardo,L.S., and Prince,D.A. (1982). Ionic mechanisms of cholinergic excitation in
mammalian hippocampal pyramidal cells. Brain Res. 249, 333-344.
10. Blitzer,R.D., Wong,T., Nouranifar,R., and Landau,E.M. (1994). The cholinergic inhibition of
afterhyperpolarization in rat hippocampus is independent of cAMP-dependent protein
kinase. Brain Res. 646, 312-314.
11. Bond,C.T., Herson,P.S., Strassmaier,T., Hammond,R., Stackman,R., Maylie,J., and Adelman,J.P.
(2004). Small conductance Ca2+-activated K+ channel knock-out mice reveal the identity of
calcium-dependent afterhyperpolarization currents. J. Neurosci. 24, 5301-5306.
12. Bond,C.T., Maylie,J., and Adelman,J.P. (1999). Small-conductance calcium-activated
potassium channels. Ann. N. Y. Acad. Sci. 868, 370-378.
13. Braunewell,K.H., and Klein-Szanto,A.J. (2009). Visinin-like proteins (VSNLs): interaction
partners and emerging functions in signal transduction of a subfamily of neuronal Ca2+
-sensor proteins. Cell Tissue Res. 335, 301-316.
14. Brown,D.A., Lancaster,B., and Shah,M.M. (2007). Hippocalcin: a new solution to an old
puzzle. Neuron 53, 467-468.
15. Burgoyne,R.D. (2007). Neuronal calcium sensor proteins: generating diversity in neuronal
Ca2+ signalling. Nat. Rev. Neurosci. 8, 182-193.

64
16. Damasio,H., Grabowski,T., Frank,R., Galaburda,A.M., and Damasio,A.R. (1994). The return of
Phineas Gage: clues about the brain from the skull of a famous patient. Science 264, 11021105.
17. Delmas,P., and Brown,D.A. (2005). Pathways modulating neural KCNQ/M (Kv7) potassium
channels. Nat. Rev. Neurosci. 6, 850-862.
18. Du,X., Zhang,H., Lopes,C., Mirshahi,T., Rohacs,T., and Logothetis,D.E. (2004). Characteristic
interactions with phosphatidylinositol 4,5-bisphosphate determine regulation of kir channels
by diverse modulators. J. Biol. Chem. 279, 37271-37281.
19. Faber,E.S., Callister,R.J., and Sah,P. (2001). Morphological and electrophysiological properties
of principal neurons in the rat lateral amygdala in vitro. J. Neurophysiol. 85, 714-723.
20. Faber,E.S., and Sah,P. (2003). Calcium-activated potassium channels: multiple contributions
to neuronal function. Neuroscientist. 9, 181-194.
21. Fisher,S.K., Novak,J.E., and Agranoff,B.W. (2002). Inositol and higher inositol phosphates in
neural tissues: homeostasis, metabolism and functional significance. J. Neurochem. 82, 736754.
22. Fuster,J.M. (2001). The prefrontal cortex--an update: time is of the essence. Neuron 30, 319333.
23. Gerber,U., Sim,J.A., and Gahwiler,B.H. (1992). Reduction of Potassium Conductances
Mediated by Metabotropic Glutamate Receptors in Rat CA3 Pyramidal Cells Does Not
Require Protein Kinase C or Protein Kinase A. Eur. J. Neurosci. 4, 792-797.

65
24. Gerlach,A.C., Maylie,J., and Adelman,J.P. (2004). Activation kinetics of the slow
afterhyperpolarization in hippocampal CA1 neurons. Pflugers Arch. 448, 187-196.
25. Goldman-Rakic,P.S. (1996). The prefrontal landscape: implications of functional architecture
for understanding human mentation and the central executive. Philos. Trans. R. Soc. Lond B
Biol. Sci. 351, 1445-1453.
26. Gulledge,A.T., Bucci,D.J., Zhang,S.S., Matsui,M., and Yeh,H.H. (2009). M1 receptors mediate
cholinergic modulation of excitability in neocortical pyramidal neurons. J. Neurosci. 29,
9888-9902.
27. Haas,H.L., and Konnerth,A. (1983). Histamine and noradrenaline decrease calcium-activated
potassium conductance in hippocampal pyramidal cells. Nature 302, 432-434.
28. Harlow,J.M. (1999). Passage of an iron rod through the head. 1848. J. Neuropsychiatry Clin.
Neurosci. 11, 281-283.
29. Higgs,M.H., Slee,S.J., and Spain,W.J. (2006). Diversity of gain modulation by noise in
neocortical neurons: regulation by the slow afterhyperpolarization conductance. J. Neurosci.
26, 8787-8799.
30. Hilgemann,D.W. (2007). Local PIP(2) signals: when, where, and how? Pflugers Arch. 455, 5567.
31. Hotson,J.R., and Prince,D.A. (1980). A calcium-activated hyperpolarization follows repetitive
firing in hippocampal neurons. J. Neurophysiol. 43, 409-419.

66
32. Jahromi,B.S., Zhang,L., Carlen,P.L., and Pennefather,P. (1999). Differential time-course of slow
afterhyperpolarizations and associated Ca2+ transients in rat CA1 pyramidal neurons: further
dissociation by Ca2+ buffer. Neuroscience 88, 719-726.
33. Janne,P.A., Suchy,S.F., Bernard,D., MacDonald,M., Crawley,J., Grinberg,A., Wynshaw-Boris,A.,
Westphal,H., and Nussbaum,R.L. (1998). Functional overlap between murine Inpp5b and
Ocrl1 may explain why deficiency of the murine ortholog for OCRL1 does not cause Lowe
syndrome in mice. J. Clin. Invest 101, 2042-2053.
34. Kammermeier,P.J., and Ikeda,S.R. (1999). Expression of RGS2 alters the coupling of
metabotropic glutamate receptor 1a to M-type K+ and N-type Ca2+ channels. Neuron 22,
819-829.
35. Kim,D., Jun,K.S., Lee,S.B., Kang,N.G., Min,D.S., Kim,Y.H., Ryu,S.H., Suh,P.G., and Shin,H.S.
(1997). Phospholipase C isozymes selectively couple to specific neurotransmitter receptors.
Nature 389, 290-293.
36. Kohler,M., Hirschberg,B., Bond,C.T., Kinzie,J.M., Marrion,N.V., Maylie,J., and Adelman,J.P.
(1996). Small-conductance, calcium-activated potassium channels from mammalian brain.
Science 273, 1709-1714.
37. Krause,M., Offermanns,S., Stocker,M., and Pedarzani,P. (2002). Functional specificity of G
alpha q and G alpha 11 in the cholinergic and glutamatergic modulation of potassium
currents and excitability in hippocampal neurons. J. Neurosci. 22, 666-673.
38. Krawczyk,D.C. (2002). Contributions of the prefrontal cortex to the neural basis of human
decision making. Neurosci. Biobehav. Rev. 26, 631-664.

67
39. Lancaster,B., and Adams,P.R. (1986). Calcium-dependent current generating the
afterhyperpolarization of hippocampal neurons. J. Neurophysiol. 55, 1268-1282.
40. Lancaster,B., and Nicoll,R.A. (1987). Properties of two calcium-activated hyperpolarizations
in rat hippocampal neurones. J. Physiol 389, 187-203.
41. Li,Y., Gamper,N., Hilgemann,D.W., and Shapiro,M.S. (2005). Regulation of Kv7 (KCNQ) K+
channel open probability by phosphatidylinositol 4,5-bisphosphate. J. Neurosci. 25, 98259835.
42. Logothetis,D.E., Jin,T., Lupyan,D., and Rosenhouse-Dantsker,A. (2007). Phosphoinositidemediated gating of inwardly rectifying K(+) channels. Pflugers Arch. 455, 83-95.
43. Madison,D.V., and Nicoll,R.A. (1986). Cyclic adenosine 3',5'-monophosphate mediates betareceptor actions of noradrenaline in rat hippocampal pyramidal cells. J. Physiol 372, 245-259.
44. Madison,D.V., and Nicoll,R.A. (1982). Noradrenaline blocks accommodation of pyramidal cell
discharge in the hippocampus. Nature 299, 636-638.
45. Markova,O., Fitzgerald,D., Stepanyuk,A., Dovgan,A., Cherkas,V., Tepikin,A., Burgoyne,R.D.,
and Belan,P. (2008). Hippocalcin signaling via site-specific translocation in hippocampal
neurons. Neurosci. Lett. 442, 152-157.
46. Marty,A. (1981). Ca-dependent K channels with large unitary conductance in chromaffin cell
membranes. Nature 291, 497-500.
47. McAdams,C.J., and Reid,R.C. (2005). Attention modulates the responses of simple cells in
monkey primary visual cortex. J. Neurosci. 25, 11023-11033.

68
48. McLaughlin,S., and Murray,D. (2005). Plasma membrane phosphoinositide organization by
protein electrostatics. Nature 438, 605-611.
49. Meyers,R., and Cantley,L.C. (1997). Cloning and characterization of a wortmannin-sensitive
human phosphatidylinositol 4-kinase. J. Biol. Chem. 272, 4384-4390.
50. Miller,E.K. (1999). The prefrontal cortex: complex neural properties for complex behavior.
Neuron 22, 15-17.
51. Nakanishi,S., Catt,K.J., and Balla,T. (1995). A wortmannin-sensitive phosphatidylinositol 4kinase that regulates hormone-sensitive pools of inositolphospholipids. Proc. Natl. Acad. Sci.
U. S. A 92, 5317-5321.
52. Nicoll,R.A. (1988). The coupling of neurotransmitter receptors to ion channels in the brain.
Science 241, 545-551.
53. O'Callaghan,D.W., Haynes,L.P., and Burgoyne,R.D. (2005). High-affinity interaction of the Nterminal myristoylation motif of the neuronal calcium sensor protein hippocalcin with
phosphatidylinositol 4,5-bisphosphate. Biochem. J. 391, 231-238.
54. Pallotta,B.S., Magleby,K.L., and Barrett,J.N. (1981). Single channel recordings of Ca2+activated K+ currents in rat muscle cell culture. Nature 293, 471-474.
55. Parsons,B.D., Schindler,A., Evans,D.H., and Foley,E. (2009). A direct phenotypic comparison
of siRNA pools and multiple individual duplexes in a functional assay. PLoS. One. 4, e8471.
56. Paterlini,M., Revilla,V., Grant,A.L., and Wisden,W. (2000). Expression of the neuronal calcium
sensor protein family in the rat brain. Neuroscience 99, 205-216.

69
57. Pedarzani,P., and Storm,J.F. (1993). PKA mediates the effects of monoamine transmitters on
the K+ current underlying the slow spike frequency adaptation in hippocampal neurons.
Neuron 11, 1023-1035.
58. Sah,P. (1995). Properties of channels mediating the apamin-insensitive
afterhyperpolarization in vagal motoneurons. J. Neurophysiol. 74, 1772-1776.
59. Sah,P. (1996a). Ca(2+)-activated K+ currents in neurones: types, physiological roles and
modulation. Trends Neurosci. 19, 150-154.
60. Sah,P., and Clements,J.D. (1999). Photolytic manipulation of [Ca2+]i reveals slow kinetics of
potassium channels underlying the afterhyperpolarization in hippocampal pyramidal
neurons. J. Neurosci. 19, 3657-3664.
61. Sah,P., and Isaacson,J.S. (1995). Channels underlying the slow afterhyperpolarization in
hippocampal pyramidal neurons: neurotransmitters modulate the open probability. Neuron
15, 435-441.
62. Sah,P., and McLachlan,E.M. (1991). Ca(2+)-activated K+ currents underlying the
afterhyperpolarization in guinea pig vagal neurons: a role for Ca(2+)-activated Ca2+ release.
Neuron 7, 257-264.
63. Saito,T. (2006). In vivo electroporation in the embryonic mouse central nervous system. Nat.
Protoc. 1, 1552-1558.
64. Saitoh,S., Takamatsu,K., Kobayashi,M., and Noguchi,T. (1994). Expression of hippocalcin in
the developing rat brain. Brain Res. Dev. Brain Res. 80, 199-208.

70
65. Sakmann,B., and Stuart,G. (1995). Patch-pipette recordings from the soma, dendrites and
axon of neurons in brain slices. In Single-channel Recording, B. Sakmann, and E. Neher, eds.
(New York: Plenum Press), pp. 199-211.
66. Schwartzkroin,P.A., and Stafstrom,C.E. (1980). Effects of EGTA on the calcium-activated
afterhyperpolarization in hippocampal CA3 pyramidal cells. Science 210, 1125-1126.
67. Schwindt,P.C., Spain,W.J., and Crill,W.E. (1992). Calcium-dependent potassium currents in
neurons from cat sensorimotor cortex. J. Neurophysiol. 67, 216-226.
68. Schwindt,P.C., Spain,W.J., Foehring,R.C., Chubb,M.C., and Crill,W.E. (1988a). Slow
conductances in neurons from cat sensorimotor cortex in vitro and their role in slow
excitability changes. J. Neurophysiol. 59, 450-467.
69. Schwindt,P.C., Spain,W.J., Foehring,R.C., Stafstrom,C.E., Chubb,M.C., and Crill,W.E. (1988b).
Multiple potassium conductances and their functions in neurons from cat sensorimotor
cortex in vitro. J. Neurophysiol. 59, 424-449.
70. Sim,J.A., Gerber,U., Knopfel,T., and Brown,D.A. (1992). Evidence Against a Role for Protein
Kinase C in the Inhibition of the Calcium-activated Potassium Current IAHP by Muscarinic
Stimulants in Rat Hippocampal Neurons. Eur. J. Neurosci. 4, 785-791.
71. Stocker,M., Krause,M., and Pedarzani,P. (1999). An apamin-sensitive Ca2+-activated K+
current in hippocampal pyramidal neurons. Proc. Natl. Acad. Sci. U. S. A 96, 4662-4667.
72. Storm,J.F. (1989). An after-hyperpolarization of medium duration in rat hippocampal
pyramidal cells. J. Physiol 409, 171-190.

71
73. Suh,B.C., and Hille,B. (2002). Recovery from muscarinic modulation of M current channels
requires phosphatidylinositol 4,5-bisphosphate synthesis. Neuron 35, 507-520.
74. Suh,B.C., and Hille,B. (2005). Regulation of ion channels by phosphatidylinositol 4,5bisphosphate. Curr. Opin. Neurobiol. 15, 370-378.
75. Suh,B.C., Inoue,T., Meyer,T., and Hille,B. (2006). Rapid chemically induced changes of
PtdIns(4,5)P2 gate KCNQ ion channels. Science 314, 1454-1457.
76. Torres,G.E., Chaput,Y., and Andrade,R. (1995). Cyclic AMP and protein kinase A mediate 5hydroxytryptamine type 4 receptor regulation of calcium-activated potassium current in
adult hippocampal neurons. Mol. Pharmacol. 47, 191-197.
77. Tzingounis,A.V., Kobayashi,M., Takamatsu,K., and Nicoll,R.A. (2007). Hippocalcin gates the
calcium activation of the slow afterhyperpolarization in hippocampal pyramidal cells. Neuron
53, 487-493.
78. Tzingounis,A.V., and Nicoll,R.A. (2008). Contribution of KCNQ2 and KCNQ3 to the medium
and slow afterhyperpolarization currents. Proc. Natl. Acad. Sci. U. S. A 105, 19974-19979.
79. Vergara,C., Latorre,R., Marrion,N.V., and Adelman,J.P. (1998). Calcium-activated potassium
channels. Curr. Opin. Neurobiol. 8, 321-329.
80. Villalobos,C., Shakkottai,V.G., Chandy,K.G., Michelhaugh,S.K., and Andrade,R. (2004). SKCa
channels mediate the medium but not the slow calcium-activated afterhyperpolarization in
cortical neurons. J. Neurosci. 24, 3537-3542.
81. Vogalis,F., Storm,J.F., and Lancaster,B. (2003). SK channels and the varieties of slow afterhyperpolarizations in neurons. Eur. J. Neurosci. 18, 3155-3166.

72
82. Watanabe,M., Nakamura,M., Sato,K., Kano,M., Simon,M.I., and Inoue,Y. (1998). Patterns of
expression for the mRNA corresponding to the four isoforms of phospholipase Cbeta in
mouse brain. Eur. J. Neurosci. 10, 2016-2025.
83. Yan,H.D., Villalobos,C., and Andrade,R. (2009). TRPC Channels Mediate a Muscarinic
Receptor-Induced Afterdepolarization in Cerebral Cortex. J. Neurosci. 29, 10038-10046.
84. Zhang,H., Craciun,L.C., Mirshahi,T., Rohacs,T., Lopes,C.M., Jin,T., and Logothetis,D.E. (2003).
PIP(2) activates KCNQ channels, and its hydrolysis underlies receptor-mediated inhibition of
M currents. Neuron 37, 963-975.

73

ABSTRACT

REGULATION OF NEURONAL EXCITABILITY: NEW MECHANISMS FOR SLOW
AFTERHYPERPOLARIZATION ACTIVATION AND MODULATION
by
CLAUDIO A. VILLALOBOS
December 2010

Advisor: Rodrigo Andrade, PhD.
Major: Pharmacology
Degree: Doctor of Philosophy
One of the most characteristic features of pyramidal cells in the prefrontal cortex
(PFC) is that they present a slow afterhyperpolarizing current (I sAHP) that plays a critical
role in the regulation of neuronal excitability. This current is modulated by receptors
acting via Gαq/11 G proteins, thus it is thought that neurotransmitters regulate neuronal
excitability through the inhibition of this current. I sAHP is known to be mediated by
calcium-activated potassium channels, however, neither the identity of the channel
underlying this current nor its mechanism of activation are yet well understood. Recent
reports have questioned a direct role of calcium in the activation of the channels
underlying the IsAHP in hippocampus, suggesting the neuronal calcium sensor (NCS)
protein hippocalcin as one of the plausible proteins involved in the triggering of I sAHP;
therefore, one of the aims of this work will be to examine the role of hippocalcin and
other NCS proteins in the development of IsAHP in pyramidal neurons of the PFC.
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In the present study we used loss of function and overexpression techniques to
demonstrate that hippocalcin is an important component in the development of the I sAHP
in pyramidal neurons of the prefrontal cortex. Furthermore, we also established that
neurocalcin-δ, a close related member of the visinin-like protein subfamily, but not
VILIP-2 produced similar effects on I sAHP. Transfection with either hippocalcin or
neurocalcin-δ also altered the kinetic of IsAHP reducing its rate of decay.
Another characteristic feature of I sAHP is that it runs down upon prolonged wholecell recordings. This rundown was reduced when a precursor of PtdIns(4,5)P 2 was
added to the recording pipette. Furthermore, blocking the resynthesis of PtdIns(4,5)P 2,
greatly increased the rate of I sAHP rundown. Reducing PtdIns(4,5)P2 levels or its
availability at the plasma membrane also significantly reduced I sAHP amplitude,
highlighting the relevance of this phospholipids in the developing of I sAHP. On the other
hand, increasing PtdIns(4,5)P2 levels at the plasma membrane, by expressing its
synthetic enzyme (PIPK5), did not significantly increased I sAHP amplitude but strongly
increased its sensibility to activation by calcium, thus ruling out a direct role of
PtdIns(4,5)P2 on activation of IsAHP in pyramidal neurons of the PFC. These results
propose the idea of an concerted mechanism of I sAHP activation between calcium influx
and PtdIns(4,5)P2 availability at the plasma membrane and present I sAHP not as a single
unitary current, but rather as the embodiment of a biochemical gating mode.
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